SII to start supplying 1st made-in-India pneumococcal conjugate vaccine to Centre from Wednesday

- India's drug regulator had in July last year granted market approval for the Pneumococcal Polysaccharide Conjugate Vaccine, after reviewing data of all the three phases of the clinical trial submitted by the SII